Collectively, these results indicated that combined treatment with NK cells and anti-PSMA Ab displayed stronger cytotoxicity and higher cytokine secretion against PCa tissues directly derived from patients, further supporting the clinical applicability of this treatment strategy. This evidence concerns the gene FOLH1 and posterior cortical atrophy.